ImmunoPrecise Antibodies Ltd: Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
Multi-target research collaboration leverages ImmunoPrecise's powerful antibody discovery technologies with the long-standing expertise of Pierre Fabre in immuno-oncology IMMUNOPRECISE ANTIBODIES
Source: finanznachrichten.de